285 related articles for article (PubMed ID: 15273324)
1. Ligand-induced changes in 2-aminopurine fluorescence as a probe for small molecule binding to HIV-1 TAR RNA.
Bradrick TD; Marino JP
RNA; 2004 Sep; 10(9):1459-68. PubMed ID: 15273324
[TBL] [Abstract][Full Text] [Related]
2. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism.
Wang S; Huber PW; Cui M; Czarnik AW; Mei HY
Biochemistry; 1998 Apr; 37(16):5549-57. PubMed ID: 9548939
[TBL] [Abstract][Full Text] [Related]
3. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.
Aboul-ela F; Karn J; Varani G
J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092
[TBL] [Abstract][Full Text] [Related]
4. Interaction of human immunodeficiency virus type 1 Tat-derived peptides with TAR RNA.
Long KS; Crothers DM
Biochemistry; 1995 Jul; 34(27):8885-95. PubMed ID: 7612630
[TBL] [Abstract][Full Text] [Related]
5. Discoveries of Tat-TAR interaction inhibitors for HIV-1.
Yang M
Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel HIV-1 TAR RNA bulge binding protein.
Baker B; Muckenthaler M; Vives E; Blanchard A; Braddock M; Nacken W; Kingsman AJ; Kingsman SM
Nucleic Acids Res; 1994 Aug; 22(16):3365-72. PubMed ID: 8078772
[TBL] [Abstract][Full Text] [Related]
7. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots".
Davis B; Afshar M; Varani G; Murchie AI; Karn J; Lentzen G; Drysdale M; Bower J; Potter AJ; Starkey ID; Swarbrick T; Aboul-ela F
J Mol Biol; 2004 Feb; 336(2):343-56. PubMed ID: 14757049
[TBL] [Abstract][Full Text] [Related]
8. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region.
Churcher MJ; Lamont C; Hamy F; Dingwall C; Green SM; Lowe AD; Butler JG; Gait MJ; Karn J
J Mol Biol; 1993 Mar; 230(1):90-110. PubMed ID: 8450553
[TBL] [Abstract][Full Text] [Related]
9. The interaction of HIV-1 Tat(32-72) with its target RNA: a fluorescence and nuclear magnetic resonance study.
Metzger AU; Bayer P; Willbold D; Hoffmann S; Frank RW; Goody RS; Rösch P
Biochem Biophys Res Commun; 1997 Dec; 241(1):31-6. PubMed ID: 9405229
[TBL] [Abstract][Full Text] [Related]
10. Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA.
Mestre B; Arzumanov A; Singh M; Boulmé F; Litvak S; Gait MJ
Biochim Biophys Acta; 1999 Apr; 1445(1):86-98. PubMed ID: 10209261
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
Arzumanov A; Walsh AP; Rajwanshi VK; Kumar R; Wengel J; Gait MJ
Biochemistry; 2001 Dec; 40(48):14645-54. PubMed ID: 11724578
[TBL] [Abstract][Full Text] [Related]
12. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
Cao H; Tamilarasu N; Rana TM
Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA.
Hamy F; Asseline U; Grasby J; Iwai S; Pritchard C; Slim G; Butler PJ; Karn J; Gait MJ
J Mol Biol; 1993 Mar; 230(1):111-23. PubMed ID: 8450529
[TBL] [Abstract][Full Text] [Related]
14. Fragments of the HIV-1 Tat protein specifically bind TAR RNA.
Weeks KM; Ampe C; Schultz SC; Steitz TA; Crothers DM
Science; 1990 Sep; 249(4974):1281-5. PubMed ID: 2205002
[TBL] [Abstract][Full Text] [Related]
15. Selective binding of TAR RNA by a Tat-derived beta-peptide.
Gelman MA; Richter S; Cao H; Umezawa N; Gellman SH; Rana TM
Org Lett; 2003 Oct; 5(20):3563-5. PubMed ID: 14507173
[TBL] [Abstract][Full Text] [Related]
16. Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition.
Calnan BJ; Biancalana S; Hudson D; Frankel AD
Genes Dev; 1991 Feb; 5(2):201-10. PubMed ID: 1899841
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of the HIV-2 TAR-argininamide complex.
Brodsky AS; Williamson JR
J Mol Biol; 1997 Apr; 267(3):624-39. PubMed ID: 9126842
[TBL] [Abstract][Full Text] [Related]
18. A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.
Roy S; Delling U; Chen CH; Rosen CA; Sonenberg N
Genes Dev; 1990 Aug; 4(8):1365-73. PubMed ID: 2227414
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure.
Dingwall C; Ernberg I; Gait MJ; Green SM; Heaphy S; Karn J; Lowe AD; Singh M; Skinner MA
EMBO J; 1990 Dec; 9(12):4145-53. PubMed ID: 2249668
[TBL] [Abstract][Full Text] [Related]
20. New inhibitors of the Tat-TAR RNA interaction found with a "fuzzy" pharmacophore model.
Renner S; Ludwig V; Boden O; Scheffer U; Göbel M; Schneider G
Chembiochem; 2005 Jun; 6(6):1119-25. PubMed ID: 15883975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
